AZD5305 hADME in Patients with Advanced Solid Malignancies

Trial Identifier:	D9723C00004
Sponsor:	AstraZeneca
Collaborator:	Fortrea
Start Date:	April 2025
Primary Completion Date:	September 2026
Study Completion Date:	September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Liverpool, GB, L7 8YA
GB	Manchester, GB, M20 4BX

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.